Outcomes | Factors | Groups | DM type | OR and 95% CI | P value | I2 (%)/PQ statistic | Ratio for OR | P value between T1DM and T2DM |
---|---|---|---|---|---|---|---|---|
All fracture | Study design | Prospective | T1DM | 1.40 (1.18–1.65) | < 0.001 | 50.6/0.108 | 1.21 (1.00–1.46) | 0.050 |
T2DM | 1.16 (1.07–1.27) | < 0.001 | 68.9/0.001 | |||||
Retrospective | T1DM | 1.86 (1.36–2.53) | < 0.001 | 99.0/< 0.001 | 1.56 (1.09–2.24) | 0.015 | ||
T2DM | 1.19 (0.99–1.43) | 0.060 | 96.6/< 0.001 | |||||
Gender | Male | T1DM | 1.50 (1.33–1.70) | < 0.001 | 51.2/0.129 | 1.25 (0.92–1.69) | 0.147 | |
T2DM | 1.20 (0.91–1.58) | 0.200 | 93.0/< 0.001 | |||||
Female | T1DM | 1.52 (1.17–1.97) | 0.002 | 88.9/< 0.001 | 1.27 (0.97–1.66) | 0.085 | ||
T2DM | 1.20 (1.12–1.28) | < 0.001 | 54.2/0.026 | |||||
Both | T1DM | 2.47 (2.36–2.58) | < 0.001 | – | 1.99 (1.40–2.83) | < 0.001 | ||
T2DM | 1.24 (0.87–1.75) | 0.232 | 87.8/< 0.001 | |||||
Hip fracture | Study design | Prospective | T1DM | 4.56 (2.49–8.34) | < 0.001 | 91.5/< 0.001 | 3.28 (1.76–6.10) | < 0.001 |
T2DM | 1.39 (1.21–1.60) | < 0.001 | 80.6/< 0.001 | |||||
Retrospective | T1DM | 3.88 (2.68–5.61) | < 0.001 | 96.0/< 0.001 | 3.43 (2.35–5.03) | < 0.001 | ||
T2DM | 1.13 (1.03–1.24) | 0.010 | 89.3/< 0.001 | |||||
Gender | Male | T1DM | 3.95 (2.10–7.43) | < 0.001 | 95.7/< 0.001 | 3.95 (2.09–7.46) | < 0.001 | |
T2DM | 1.00 (0.93–1.08) | 0.946 | 36.5/0.178 | |||||
Female | T1DM | 4.76 (2.66–8.52) | < 0.001 | 95.9/< 0.001 | 3.33 (1.83–6.05) | < 0.001 | ||
T2DM | 1.43 (1.25–1.64) | < 0.001 | 88.2/< 0.001 | |||||
Both | T1DM | 2.41 (2.20–2.65) | < 0.001 | – | 2.15 (1.80–2.58) | < 0.001 | ||
T2DM | 1.12 (0.96–1.31) | 0.136 | 41.0/0.132 |